A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
Clinical trial NCT02018510 · COMPLETED
Trial details
- NCT number
- NCT02018510
- Sponsor
- Rockefeller University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-01-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.